Roche will pay as much as $580 million in R&D pact with Galapagos

01/11/2010 | Reuters

Galapagos agreed to give Roche Holding worldwide rights for its treatments for chronic obstructive pulmonary disease. Roche will pay Galapagos as much as $580 million and handle development after early-stage trials.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN